Asia-Pacific Adhesion Barrier Market was worth USD 152.76 million in 2018 and estimated to be growing at a CAGR of 10.1%, to reach USD 247.14 million by 2023. An adhesion barrier is a medical implant that can be used to reduce abnormal internal scarring (adhesions) following surgery by separating the internal tissues and organs while they heal.
An adhesion barrier is a medical device used to avoid adhesion occurred during surgery. Adhesion barrier is used to separate internal tissues and organ to avoid formation of scar tissues named adhesion. Visceral or parietal peritoneum damage leads to adhesion formation. Adhesion can lead to chronic pain, bowel obstruction and infertility. These are common risk occurred during surgery. Abdominal surgery gives rise to large number of adhesions compared to other procedure.
Major driving forces of the market are growing geriatric population, increasing number of surgical procedures, rising incidences of sports related and Hand & Wrist injuries and increasing funding for R&D to make novel and innovative products. But, factors like high cost, limited technological developments due to stringent regulations and presence of alternative surgical techniques which are minimally invasive are going to hinder the growth of market.
The Asia-Pacific market for Adhesion Barrier is segmented based on Product, Product Form and Application. Based on Product – Synthetic Adhesion Barriers and Natural Adhesion Barriers. Synthetic is further segmented into Regenerated Cellulose, Hyaluronic Acid, Polythene Glycol and others. Natural is further segmented to Fibrin, Collagen & Protein. Based on Product Form - Film Adhesion Barriers, Gel Adhesion Barriers and Liquid Adhesion Barriers. Based on Surgical Applications – Gynaecological, Cardiovascular, Neurological, Orthopaedic, General/Abdominal, Urological, Reconstructive Surgeries. Based on Geographical analysis the market is separated into regions of China, India, Japan, South-Korea and Australia. China is leading the market due to presence of market leaders as well as well-developed healthcare infrastructure. However India is expected to grow the fastest due to increasing awareness regarding adhesion barriers, developing healthcare infrastructure and rising disposable income levels. Synthetic adhesion barriers hold the major share in terms of products due to widespread use of products such as hyaluronic acid and regenerated cellulose in surgeries. Film type adhesion barriers held the major share in terms of product form due to prevalent use in laparoscopic surgeries.
Some of the key players dominating this market include Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc., and MAST Biosurgery AG.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Synthetic Adhesion Barriers
5.1.2.1 Regenerated Cellulose
5.1.2.2 Hyaluronic Acid
5.1.2.3 Polythene Glycol
5.1.3 Natural Adhesion Barriers
5.1.3.1 Fibrin
5.1.3.2 Collagen & Protein
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Product Form
5.2.1 Introduction
5.2.2 Film Adhesion Barriers
5.2.3 Gel Adhesion Barriers
5.2.4 Liquid Adhesion Barriers
5.2.5 Y-o-Y Growth Analysis, By Product Form
5.2.6 Market Attractiveness Analysis, By Product Form
5.2.7 Market Share Analysis, By Product Form
5.3 Surgical Applications
5.3.1 Introduction
5.3.2 Gynaecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Neurological Surgeries
5.3.5 Orthopaedic Surgeries
5.3.6 General/Abdominal Surgeries
5.3.7 Urological Surgeries
5.3.8 Reconstructive Surgeries
5.3.9 Other Surgeries
5.3.10 Y-o-Y Growth Analysis, By Surgical Applications
5.3.11 Market Attractiveness Analysis, By Surgical Applications
5.3.12 Market Share Analysis, By Surgical Applications
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Product Form
6.1.3.4 By Surgical Applications
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Product Form
6.1.4.4 By Surgical Applications
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Product Form
6.1.5.4 By Surgical Applications
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc.
8.3 C. R. Bard, Inc.
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 Integra Lifesciences Corporation
8.8 Anika Therapeutics Inc.
8.9 FzioMed, Inc.
8.10 MAST Biosurgery AG
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
